Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Vericel Corporation
Vericel Reports Third Quarter 2024 Financial Results
November 07, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
October 24, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
August 29, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
August 26, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
August 15, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
August 07, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
July 22, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
July 18, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
June 11, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
May 22, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
May 08, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
April 24, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
February 29, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
February 27, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
February 15, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
February 05, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
January 09, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
January 03, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
November 08, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Stephens Annual Investment Conference
November 07, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
October 25, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
September 28, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
September 20, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Morgan Stanley Global Healthcare Conference
September 06, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
August 02, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023
July 20, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
May 10, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023
April 26, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023
February 28, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.